title: Low-dose interleukin-2 therapy is not associated with cutaneous toxicity after autologous transplantation.
authors.forename: J
authors.initials: J
authors.lastname: López-Jiménez
authors.forename: E
authors.initials: E
authors.lastname: De las Heras
authors.forename: Y
authors.initials: Y
authors.lastname: Hilara
authors.forename: J
authors.initials: J
authors.lastname: García-Laraña
authors.forename: J
authors.initials: J
authors.lastname: Pérez-Oteyza
authors.forename: C
authors.initials: C
authors.lastname: Bellas
authors.forename: A
authors.initials: A
authors.lastname: Muñoz
authors.forename: A
authors.initials: A
authors.lastname: Rocamora
authors.forename: M
authors.initials: M
authors.lastname: Núñez
authors.forename: J
authors.initials: J
authors.lastname: Odriozola
mesh_terms: D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007376:Interleukin-2 / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012867:Skin / Q000187:drug effects*; D014182:Transplantation, Autologous
chemical_list: D007376:Interleukin-2